AUTOIMMUNE THYROIDITIS AND TARGETED ANTI-T CELL IMMUNOTHERAPY IN MAN

References

• Miller Jfap. Lymphocyte interactions in antibody responses. Int Rev Cytol 1972; 33: 77–130
   PubMedGoogle Scholar
• Wraith D C, McDevitt H O, Steinman L, Acha‐Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989; 57: 709–715
   PubMed Web of Science ®Google Scholar
• Tunbridge W MG, Evered D C, Hall R, Appleton D, Brewis M, Clark F, Grimley Evans J, Young E, Bird T, Smith P A. The spectrum of thyroid disease in a community: the Whickham survey. Clin Encocrinol (Oxf 1977; 7: 481–493
   PubMed Web of Science ®Google Scholar
• Roitt I M, Doniach D, Campbell P N, Hudson R V. Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet 1956; ii: 820–821
   Google Scholar
• Malthiery Y, Lissitzky S. Primary structure of human thyro‐globulin deduced from the sequence of its 8448 base complementary DNA. EurJ Biochem 1987; 165: 491–498
   PubMedGoogle Scholar
• Kimura S, Kotani T, McBridge O W, Umeki K, Hirai J M, Nakayama T, Ohtaki S. Human thyroid peroxidase: complete cDNA and protein sequence. Proc Natl Acad Sci USA 1987; 84: 5555–5559
   PubMed Web of Science ®Google Scholar
• Seto P, Hirayu H, Magnusson R P, Gestautas J, Portmann L, DeGroot L J, Rapoport B. Isolation of complementary DNA clone for thyroid microsomal antigen: homology with the gene for thyroid peroxidase. J Clin Invest 1987; 80: 1205–1208
   PubMed Web of Science ®Google Scholar
• Parmentier M, Libert F, Maenhaut C, Lefort A, Gerard C, Perrett J, Van Sande J, Dumont J E, Vassart G. Molecular cloning of the thyrotropin receptor. Science 1989; 246: 1620–1622
   PubMed Web of Science ®Google Scholar
• Nagayama Y, Kaufman K D, Seto P, Rapoport B. Molecular cloning, sequencing and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 1989; 165(3)1184–1190
   PubMed Web of Science ®Google Scholar
• Londei M, Bottazzo G F, Feldmann M. Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
   PubMed Web of Science ®Google Scholar
• Grubeck‐Loebenstein B, Londei M, Greenall C, Pirich K, Kassal K, Waldhausl W, Feldmann M. Pathogenic relevance of HLA class II expressing thyroid follicular cells in nontoxic goiter and in Graves' disease. J Clin Invest 1988; 81: 1608–1614
   PubMed Web of Science ®Google Scholar
• Weetman A P, Volkman D J, Burman K D, Margolick J B, Petrick P, Weintraub B D, Fauci A S. The production and characterisation of thyroid‐derived T cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol 1986; 39: 139–150
   PubMedGoogle Scholar
• Del Prete G F, Mariotti S, Tiri A, Ricci M, Pinchera A, Romagnani S. Characterisation of thyroid infiltrating lymphocytes in Hashimoto's thyroiditis. Acta Endocrinol (Copenh) Suppl 1987; 281: 111–115
   Google Scholar
• Hanafusa T, Chiovato L, Doniach D, Pujol‐Borrell R, Russell C G, Bottazzo G F. Aberrant expression of HLA.‐DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983; ii: 1111–1115
   Google Scholar
• Grubeck‐Loebenstein B, Buchan G, Chantry D, Kassal K, Londei M, Pirich K, Barrett K, Turner M, Waldhausl W, Feldmann M. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce inlerleukin‐la and interleukin‐6. Clin Exp Immunol 1989; 77: 324–330
   PubMed Web of Science ®Google Scholar
• Zheng Rqh, Abney E, Chu C Q, Field M, Grubeck‐Loebenstein B, Maini R N, Feldmann M. Detection of interleukin‐6 and interleukin‐1 production in human thyroid epithelial cells by non‐radioactive in situ hybridisation and immunohistochemical methods. Clin Exp Immunol 1991; 83: 314–319
   PubMedGoogle Scholar
• Weetman A P, Cohen S, Makgoba M W, Borysiewicz L K. Expression of an intracellular adhesion molecule, ICAM‐1, by human thyroid cells. J Endocrinol 1989; 122: 185–191
   PubMed Web of Science ®Google Scholar
• Zheng R QH, Abney E, Grubeck‐Loebenstein B, Dayan C M, Maini R N, Feldmann M. Expression of intercellular adhesion molecule‐1 and lymphocyte function associated antigen‐3 on human thyroid epithelial cells. J Autoimmune 1991; 3: 727–736
   Web of Science ®Google Scholar
• Londei M, Lamb J R, Botazzo G F, Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Doniach D, Bolazzo G F, Drexhage H A. The autoimmune endo‐crinopathies. Clinical Aspects of Immunology, P J Lachmann, D K Peters. Blackwell Scientific Publications, Oxford 1982; Vol 2: 903–937
   Google Scholar
• Moore G RW, McCarron R M, McFarlin D E, Raine C S. Chronic relapsing necrotising encephalomyelitis produced by myelin basic protein in mice. Lab Invest 1987; 57: 157–167
   PubMed Web of Science ®Google Scholar
• Zamvil S S, Mitchell D J, Moore A C, Kitamura K, Steinman L, Rothbard J B. T‐cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986; 324: 258–260
   PubMed Web of Science ®Google Scholar
• Zamvil S S, Nelson P, Trotter J, Mitchell D J, Knobler R, Fritz R, Steiman L. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985; 317: 355
   PubMed Web of Science ®Google Scholar
• Acha‐Orbea H, Mitchell D J, Timmerman L, Wraith D C, Tausch G S, Waldor M K, Zamvil S S, McDevitt H O, Steinman L. Limited hereogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventions. Cell 1988; 54: 263–273
   PubMed Web of Science ®Google Scholar
• Urban J L, Kumar V, Kono D H, Gomez C, Horvath S J, Clayton J, Ando D G, Sercarz E E, Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 1988; 54: 577–592
   PubMed Web of Science ®Google Scholar
• Wraith D C, Smilek D E, Mitchell D J, Steinman L, McDevitt H O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide‐mediated immunotherapy. Cell 1989; 59: 247–255
   PubMed Web of Science ®Google Scholar
• Urban J L, Horvath S J, Hood L. Autoimmune T cells: immune recognition of normal and variant peptide epitopes and peptide‐based therapy. Cell 1989; 59: 257–271
   PubMed Web of Science ®Google Scholar
• Acha‐Orbea H, Steinman L, McDevitt H O. T cell receptors in murine autoimmune diseases. Ann Rev Immunol 1989; 7: 371–405
   PubMed Web of Science ®Google Scholar
• Dawe K, Page K R, Rayner D C, Hutchings P, Cooke A, Geysen M, Roitt I, Champion B R. Thyroglobulin T cell epitopes and their role in murine experimental autoimmune thyroiditis. J CellBiochem 1991, Suppl 15A: 310, (Abstract)
   Google Scholar
• Ben‐Nun A, Wekerle H, Cohen I R. Vaccination against autoimmune encephalomyelitis with T‐lymphocyte line reactive against myelin basic protein. Nature 1981; 292: 60–61
   PubMed Web of Science ®Google Scholar
• Holoshitz J, Naparstek Y, Ben‐Nun A, Cohen I R. Lines of T‐lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983; 219: 56–58
   PubMed Web of Science ®Google Scholar
• Maron R, Zerubavel R, Friedman A, Cohen I R. T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis. J Immunol 1983; 131: 2316
   PubMed Web of Science ®Google Scholar
• Vandenbark A A, Hasim G, Offner H. Immunisation with a synthetic T‐cell receptor V‐region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–544
   PubMed Web of Science ®Google Scholar
• Howell M D, Winters S T, Olee T, Powell H C, Carlo D J, Brostoff S W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Offner H, Hashim G, Vandenbark A A. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991; 251: 430–432
   PubMed Web of Science ®Google Scholar
• Harcourt G C, Sommer N, Rothbard J B, Wilcox H NA, Newsom‐Davis J. A juxtamembrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. J Clin Invest 1988; 82: 1295–1300
   PubMed Web of Science ®Google Scholar
• Melms A, Chrestel S, Scalke B CG, Wekerle H, Mauron A, Ballivet M, Barkas T. Autoimmune T lymphocytes in myasthenia gravis. J Clin Invest 1989; 83: 785–790
   PubMed Web of Science ®Google Scholar
• Zhang Y, Schluep M, Fritiger S, Hughes G J, Steck A, Barkas T. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients. Eur J Immunol 1990; 20: 2577–2583
   PubMed Web of Science ®Google Scholar
• Ota K, Matsui M, Milford E L, Mackin G A, Weiner H L, Hafler D A. T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346: 183–187
   PubMed Web of Science ®Google Scholar
• Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long E O, McFarlin D E, McFarland H F. Fine specificity and HLA restriction of myelin basic‐protein specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990; 145: 540–548
   PubMed Web of Science ®Google Scholar
• Martin R, Howell M D, Jaraquemada D, Flerlage M, Richert J, Brostoff S W, Long E O, McFarlin D E, McFarland H F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA.‐DR types associated with multiple sclerosis. J Exp Med 1991; 173: 19–24
   PubMed Web of Science ®Google Scholar
• Pette M, Fujita K, Wilkinson D, Altmann D M, Trowsdale J, Giegerich G, Hinkkanen A, Epplen J T, Kappos L, Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA.‐DR2 products by T lymphocytes of multiple‐sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990; 87: 7968–7972
   PubMed Web of Science ®Google Scholar
• Jingwu Z, Chou C ‐H. J, Hashim G, Medaer R, Raus J CM. Preferential peptide specificity and HLA restriction of myelin basic protein‐specific T cell clones derived from MS patients. Cell Immunol 1990; 129: 189–198
   PubMed Web of Science ®Google Scholar
• Liblau R, Tournier‐Lasserve E, Maciazek J, Dumas G, Siffert O, Hashim G, Bach M ‐A. T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects. Eur J Immunol 1991; 21: 1391–1395
   PubMed Web of Science ®Google Scholar
• Canonica G W, Cosulich M E, Croci R, Ferrini S, Bagnasco M, Dirienzo W, Ferrini O, Bargellesi A, Giordano G. Thyroglobul‐in‐induced T cell in vitro proliferation in Hashimoto's thyroiditis: identification of the responsive subset and effects of monoclonal antibodies directed to la antigens. Clin Immunol Immunopathol 1984; 32: 132
   PubMedGoogle Scholar
• Shimojo N, Saito K, Kohno Y, Sasaki N, Tarutani O, Sakajima H. Antigenic determinants on thyroglobulin: comparison of the reactivities of different thyroglobulin preparations with serum antibodies and T cells of patients with chronic thyroiditis. J Clin Endocrinol Metab 1988; 66: 689–695
   PubMed Web of Science ®Google Scholar
• Fukuma N, McLachlan S M, Rapoport B, Goodacre J, Middleton S L, Phillips D IW, Pegg C AS, Rees Smith B. Thyroid antigens and human T cell responses. Clin Exp Immunol 1990; 82: 275–283
   PubMed Web of Science ®Google Scholar
• Burns J, Rosenzweig A, Zweiman B, Lisak R P. Isolation of myelin basic protein‐reactive lines from normal human blood. Cell Immunol 1983; 81: 435
   PubMed Web of Science ®Google Scholar
• Olsson T, Zhi W W, Hojeberg B, Kostulas V, Yu‐Ping J, Anderson G, Ekre H ‐P, Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of inter‐feron‐gamma. J Clin Invest 1990; 86: 981–985
   PubMed Web of Science ®Google Scholar
• Van Oers M HJ, Pinkster J, Zeijlemaker W P. Quantification of antigen‐reactive cells among human lymphocytes. Eur J Immunol 1978; 8: 477–184
   PubMed Web of Science ®Google Scholar
• Dayan C M, Londei M, Corcoran A, Grubeck‐Loebenstein B, James R FL, Rapoport B, Feldmann M. Autoantigen recognition by thyroid infiltrating T cells in Graves' disease. Proc Natl Acad Sci USA 1991; 88: 7415–7419
   PubMed Web of Science ®Google Scholar
• Batchelor J R, Welsh K I. Association of HLA antigens with disease. Clinical Aspects of Immunology, P J Lachmann, D K Peters. Blackwell Scientific Publications, OxfordUK 1982; Vol 1: 283–306
   Google Scholar
• Mackenzie W A, Schwartz A E, Friedman E W, Davies T F. Intra‐thyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1987; 64(4)818–824
   PubMed Web of Science ®Google Scholar
• Fisfalen M E, DeGroot L J, Quintans J, Franklin W A, Soltani K. Microsomal antigen‐reactive lymphocyte lines and clones from thyroid tissue of patients with Graves' disease. J Clin Endocrinol Metab 1988; 66: 776–784
   PubMed Web of Science ®Google Scholar
• Lipoldova M, Londei M, Grubeck‐Loebenstein B, Feldmann M, Owen M J. Analysis of T‐cell receptor usage in activated T‐cell clones from Hashimoto's thyroiditis and Graves' disease. J Autoimmune 1989; 2: 1–13
   PubMed Web of Science ®Google Scholar
• Kaulfersch W, Baker J R, Burman K D, Ahmann A J, ďAvis J C, Waldmann T A. Immunoglobulin and T cell antigen receptor gene arrangements indicate that the immune response in autoimmune thyroid disease is polyclonal. J Clin Endocrinol Metab 1988; 66: 958–963
   PubMed Web of Science ®Google Scholar
• Cooke A. Is there restricted T cell receptor usage in autoimmune disease?. Clin Exp Immunol 1991; 83: 345–346
   PubMed Web of Science ®Google Scholar
• Wenzel B E, Heeseman J, Wenzel K W, Scriba P C. Antibodies to plasmid‐encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; i: 56
   Google Scholar
• Volpe R. Antibodies to plasmid‐encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; i: 647–647
   Google Scholar
• Byfield P GH, Davies S C, Copping S, Barclay F E, Borriello S P. Thyrotrophin (TSH)‐binding proteins in bacteria and their cross‐reaction with autoantibodies against human TSH receptor. J Endocrinol 1989; 121: 571–577
   PubMed Web of Science ®Google Scholar
• Bech K, Larsen J H, Hansen J M, Nerup J. Yersinia enterocolit‐ica infection and thyroid disorders. Lancet 1974; ii: 951–952
   Google Scholar
• Oldstone M B. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819–820
   PubMed Web of Science ®Google Scholar
• Tunbridge W MG, Brewis M, French J M, Appleton D, Bird T, Clark F, Evered D C, Evans Grimley J, Hall R, Smith P, Stephenson J, Young E. Natural history of autoimmune thyroiditis. Br Med J 1981; 282: 258–282
   PubMed Web of Science ®Google Scholar
• McGregor A M. Autoantibodies to the TSH receptor in patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 1990; 33: 683–685
   PubMed Web of Science ®Google Scholar
• Hamada N, Jaeduck N, Portmann L, Ito K, DeGroot L J. Antibodies against denatured and reduced thyroid microsomal antigen in autoimmune thyroid disease. J Clin Endocrinol Metab 1987; 64: 230–238
   PubMed Web of Science ®Google Scholar
• Doble N D, Banga J P, Pope R, Lalor E, Kilduff P, McGregor A M. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunol 1988; 64: 23–29
   PubMed Web of Science ®Google Scholar
• Banga J P, Barnett P S, Ewins D L, Page M J, McGregor A M. Mapping of autoantigenic epitopes on recombinant thyroid peroxidase using the polymerase chain reaction. Autoimmunity 1990; 6: 257–268
   PubMed Web of Science ®Google Scholar
• Bresler H S, Burek C L, Hoffman W H, Rose N R. Autoantigenic determinants on human thyroglobulin. Clin Immunol Immuno‐pathol 1990; 54: 76–86
   PubMedGoogle Scholar
• Henry M, Malthiery Y, Zanelli E, Charvet B. Epitope mapping of human thyroglobulin. J Immunol 1990; 145: 3692–3698
   PubMed Web of Science ®Google Scholar
• Zakarija M. Immunochemical characterisation of the thyroid‐stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J Clin Lab Immunol 1983; 10: 77–85
   PubMedGoogle Scholar
• Knight J, Laing P, Knight A, Adams D, Ling N. Thyroid‐stimulating antibodies usually contain only lambda‐light chains: evidence for the “forbidden clone” theory. Clin Endocrinol Me tab 1986; 62: 342–347
   PubMed Web of Science ®Google Scholar
• Worthington J, Byfield P GH, Himsworth R L. Heterogeneity of circulating TSH‐receptor antibodies in thyroid disease demonstrated directly by chromatography. Clin Endocrinol (Oxf) 1991; 34: 147–154
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that cross‐reacts with an eye muscle cell surface antigen may be the cause of thyroid‐associated ophthalmopathy. J Clin Endocrinol Metab 1988; 67: 565–570
   PubMed Web of Science ®Google Scholar
• Perros P, Kendall‐Taylor P. The pathogenesis of thyroid‐associated ophthalmopathy. J Endocrinol 1989; 122: 619–624
   PubMed Web of Science ®Google Scholar
• Weetman A P, McGregor A M, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol (Oxf) 1984; 21: 163–172
   PubMed Web of Science ®Google Scholar
• Pinchera A, Liberti P, Martino E, Fenzi G F, Grasso L, Rovis L, Baschieri L. Effects of antithyroid therapy on the long‐acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab 1969; 29: 231–238
   PubMed Web of Science ®Google Scholar
• Karlsson F A, Dahlberg P A. Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease. Clin Endocrinol (Oxf) 1981; 14: 579
   PubMed Web of Science ®Google Scholar
• McGregor A M, Ibbertson H K, Rees Smith B, Hall R. Carbima‐zole and autoantibody synthesis in Hashimoto's thyroiditis. Br Med J 1980; 281: 968–969
   PubMedGoogle Scholar
• McGregor A M, Petersen M M, McLaehlan S M, Rooke P, Rees Smith B, Hall R. Carbimazole and the autoimmune response in Graves' disease. New EnglJ Med 1991; 303: 302–307
   Google Scholar
• Wilson R, McKillop J H, Buchanan L M, Bradley H, Smith W E, Thomson J A. The effect of carbimazole therapy on interleukin 2, interleukin 2 receptors and free radicals. Autoimmunity 1990; 8: 3–7
   PubMed Web of Science ®Google Scholar
• Chow C C, Lai K N, Leung J CK, Chan J CN, Cockram C S. Serum soluble interleukin 2 receptor in hyperthyroid Graves' disease and effect of carbimazole therapy. Clin Endocrinol (Oxf) 1990; 33: 317–321
   PubMed Web of Science ®Google Scholar
• Hedley A J, Young R E, Jones S J, Alexander W D, Bewsher P D. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long term follow‐up of 434 patients. Clin Endocrinol (Oxf) 1989; 31: 209–218
   PubMed Web of Science ®Google Scholar
• Beck J S, Young R J, Simpson J G, Gray E S, Nicol A G, Pegg C AS, Michie W. Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis. Br J Surg 1973; 60: 769–771
   PubMed Web of Science ®Google Scholar
• Rennie D P, McGregor A M, Keast D, Weetman A P, Foord S M, Dieguez C, Williams E D, Hall R. The influence of methima‐zole on thyroglobulin‐induced autoimmune thyroiditis in the rat. Endocrinol 1983; 112: 326–330
   PubMed Web of Science ®Google Scholar
• Hallengren B, Forsgren A, Melander A. Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab 1980; 51: 298–301
   PubMed Web of Science ®Google Scholar
• McGregor A M, Rees Smith B, Hall R, Collins P N, Bottazzo G F, Petersen M M. Specificity of the immunosuppressive action of carbimazole in Graves' disease. Br Med J 1982; 284: 1750–1751
   PubMed Web of Science ®Google Scholar
• How J, Bewsher P D, Home C HW. Specificity of the immunosuppressive action of carbimazole in Graves' disease. Br Med J 1982; 285: 137
   PubMedGoogle Scholar
• Jansson R, Dahlberg P A, Johansson H, Lindstrom B. Intra‐thyroidal concentrations of methimazolc in patients with Graves' disease. Clin Endocrinol Metab 1983; 57: 129–132
   Google Scholar
• Weetman A P, McGregor A M, Hall R. Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol 1983; 28: 39–45
   PubMedGoogle Scholar
• Weetman A P, Holt M E, Campbell A K, Hall R, McGregor A M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br Med J 1984; 288: 518–520
   PubMed Web of Science ®Google Scholar
• Volpe R, Karlsson F A, Jansson R, Dahlberg P A. Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) 1986; 25: 453
   PubMed Web of Science ®Google Scholar
• Weetman A P, Bright‐Thomas R, Freeman M. Regulation of interleukin‐6 release by human thyrocytes. J Endocrinol 1990; 127: 357–361
   PubMed Web of Science ®Google Scholar
• Weetman A P, Freeman M, Borysiewicz L R, Makgoba M W. Functional analysis of intercellular adhesion molecule‐1‐expressing human thyroid cells. Eur J Immunol 1990; 20: 271–275
   PubMed Web of Science ®Google Scholar
• Schumm‐Draeger P ‐M, Boehm B O, Wenisch H JC, Schoffling K. Effects of γ‐interferon interleukin‐2 on xenotransplanted human thyroid tissue. Autoimmune Thyroiditis: Approaches Towards its Etiological Differentiation, W A Scherbaum, U Bigner, G F Bottazzo. G. Thieme, Stuttgart 1991, in press
   Google Scholar
• Wenzel B E, Gutekunst R, Grammerstorf S, Scriba P C. An in vitro model for thyroid autoimmunity. Thyroid Autoimmunity, A Pinchera, S H Ingbar, J M McKenzie, G F Fenzi. Plenum, New York 1987; 145–152
   Google Scholar
• Kendall‐Taylor P. The management of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1989; 31: 747–756
   PubMed Web of Science ®Google Scholar